"Solasia and Nippon Kayaku Announce License Agreement in Japan for New Drug Candidate DARINAPARSIN (SP-02) https://t.co/8VUSg7JWPd"

Zinapar (darinaparsin) - Solasia, Meiji Seika, Nippon Kayaku

Oct 26, 2021